The Food and Drug Administration halted sales of the popular DNA-testing kit by 23andMe last week. The FDA is unsure that 23andMe's Personal Genome Service does what it promises, and says the company needs the regulatory approval of the FDA. The company and the agency have met face-to-face 14 times in the last five years, but, the FDA says, "... we still do not have any assurance that the firm has analytically or clinically validated the PGS for its intended uses, which have expanded from the uses that the firm identified in its submissions." RT's Ameera David talks with Jeremy Gruber, president of the Council for Responsible Genetics, about the implications of the FDA halting sales of 23andMe's PGS test kit. Find RT America in your area: http://rt.com/where-to-watch/ Or watch us online: http://rt.com/on-air/rt-america-air/ Like us on Facebook http://www.facebook.com/RTAmerica Follow us on Twitter http://twitter.com/RT_America
We want your Vids and Blog for Mashups.....CLICK HERE
No comments:
Post a Comment